A Quality Approach to Blinatumomab Delivery in Pediatric Oncology: A Children's Oncology Group Study
{{output}}
Background: Blinatumomab is a promising immunotherapy agent that has been shown to improve survival outcomes in children diagnosed with relapsed B-lineage acute lymphoblastic leukemia. Expanded use of blinatumomab in the treatment of childhood cancer is expect... ...
